Genomic modulators of the immune response

Trends in Genetics

Volumn 29, Issue 2, 2013, Pages 74-83

  Knight, Julian C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Autoimmunity; Gene regulation; Immunity; Immunodeficiency; Leukocyte; Major histocompatibility complex

Indexed keywords

ADAM PROTEIN; CD40 ANTIGEN; HLA B27 ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 17; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ASTHMA; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; CANDIDIASIS; EXOME; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EPIGENOMICS; EXOME; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; IMMUNITY; IMMUNOLOGIC DEFICIENCY SYNDROMES; SEQUENCE ANALYSIS, DNA;

EID: 84872839742     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2012.10.006     Document Type: Review

References (85)

1. Casanova J.L., et al. Inborn errors of human JAKs and STATs. Immunity 2012, 36:515-528.
2. Cunningham-Rundles C. Human B cell defects in perspective. Immunol. Res. 2012, 54:227-232.
3. van der Burg M., et al. New frontiers of primary antibody deficiencies. Cell. Mol. Life Sci. 2012, 69:59-73.
4. Knight J.C. Understanding human genetic variation in the era of high-throughput sequencing. EMBO Rep. 2010, 11:650-652.
5. Bamshad M.J., et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 2011, 12:745-755.
6. Cho J.H., Gregersen P.K. Genomics and the multifactorial nature of human autoimmune disease. N. Engl. J. Med. 2011, 365:1612-1623.
7. Cotsapas C., et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 2011, 7:e1002254.
8. Montgomery S.B., Dermitzakis E.T. From expression QTLs to personalized transcriptomics. Nat. Rev. Genet. 2011, 12:277-282.
9. Nicolae D.L., et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010, 6:e1000888.
10. Majewski J., Pastinen T. The study of eQTL variations by RNA-seq: from SNPs to phenotypes. Trends Genet. 2010, 27:72-79.
11. Durbin R.M., et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.
12. Knight J.C. Resolving the variable genome and epigenome in human disease. J. Intern. Med. 2012, 271:379-391.
13. Consortium E.P. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
14. Rakyan V.K., et al. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 2011, 12:529-541.
15. Fernandez-Morera J.L., et al. Epigenetic regulation of the immune system in health and disease. Tissue Antigens 2010, 76:431-439.
16. Notarangelo L.D. Primary immunodeficiencies. J. Allergy Clin. Immunol. 2010, 125:S182-S194.
17. Boisson-Dupuis S., et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 2012, 24:364-378.
18. de Preval C., et al. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 1985, 318:291-293.
19. Reith W., Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 2001, 19:331-373.
20. Metzger T.C., Anderson M.S. Control of central and peripheral tolerance by Aire. Immunol. Rev. 2011, 241:89-103.
21. Bennett C.L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
22. Wildin R.S., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
23. Liu L., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 2011, 208:1635-1648.
24. Radojkovic M., et al. Novel ORC4L gene mutation in B-cell lymphoproliferative disorders. Am. J. Med. Sci. 2009, 338:527-529.
25. Chapel H. Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011. Clin. Exp. Immunol. 2012, 168:58-59.
26. Ferreira R.C., et al. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat. Genet. 2010, 42:777-780.
27. Ferreira R.C., et al. High-density SNP mapping of the HLA region identifies multiple independent susceptibility loci associated with selective IgA deficiency. PLoS Genet. 2012, 8:e1002476.
28. Strange A., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 2010, 42:985-990.
29. Smyth D.J., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 2006, 38:617-619.
30. Nejentsev S., et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
31. Wang N., et al. Selective IgA deficiency in autoimmune diseases. Mol. Med. 2011, 17:1383-1396.
32. Zhernakova A., et al. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 2009, 10:43-55.
33. Sanseau P., et al. Use of genome-wide association studies for drug repositioning. Nat. Biotechnol. 2012, 30:317-320.
34. Franke A., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 2010, 42:1118-1125.
35. Trowsdale J. The MHC, disease and selection. Immunol. Lett. 2011, 137:1-8.
36. Lederberg J. Haldane J.B.S. (1949) on infectious disease and evolution. Genetics 1999, 153:1-3.
37. Zhernakova A., et al. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am. J. Hum. Genet. 2010, 86:970-977.
38. Vandiedonck C., Knight J.C. The human major histocompatibility complex as a paradigm in genomics research. Brief. Funct. Genomic Proteomic 2009, 8:379-394.
39. Iqbal Z., et al. De novo assembly and genotyping of variants using colored de Bruijn graphs. Nat. Genet. 2012, 44:226-232.
40. Leslie S., et al. A statistical method for predicting classical HLA alleles from SNP data. Am. J. Hum. Genet. 2008, 82:48-56.
41. Monsuur A.J., et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS ONE 2008, 3:e2270.
42. Kuchroo V.K., et al. Dysregulation of immune homeostasis in autoimmune diseases. Nat. Med. 2012, 18:42-47.
43. Raychaudhuri S., et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 2012, 44:291-296.
44. Evans D.M., et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 2011, 43:761-767.
45. Payeli S.K., et al. Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondyloarthritis. Arthritis Rheum. 2012, 64:3139-3149.
46. Pelak K., et al. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol. 2011, 9:e1001208.
47. Silverberg M.S., et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat. Genet. 2009, 41:216-220.
48. Fairfax B.P., et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat. Genet. 2012, 44:502-510.
49. Rioux J.D., et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:18680-18685.
50. Thomas R., et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 2009, 41:1290-1294.
51. Kulkarni S., et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011, 472:495-498.
52. Vandiedonck C., et al. Pervasive haplotypic variation in the spliceo-transcriptome of the human major histocompatibility complex. Genome Res. 2011, 21:1042-1054.
53. Cookson W., et al. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 2009, 10:184-194.
54. Rockman M.V., Kruglyak L. Genetics of global gene expression. Nat. Rev. Genet. 2006, 7:862-872.
55. Moffatt M.F., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007, 448:470-473.
56. Fu J., et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet. 2012, 8:e1002431.
57. Fehrmann R.S., et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet. 2011, 7:e1002197.
58. Nica A.C., et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 2011, 7:e1002003.
59. Plagnol V., et al. Statistical independence of the colocalized association signals for type 1 diabetes and RPS26 gene expression on chromosome 12q13. Biostatistics 2009, 10:327-334.
60. Reich D., et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet. 2009, 5:e1000360.
61. Nalls M.A., et al. Multiple loci are associated with white blood cell phenotypes. PLoS Genet. 2011, 7:e1002113.
62. Okada Y., Kamatani Y. Common genetic factors for hematological traits in humans. J. Hum. Genet. 2012, 57:161-169.
63. Okada Y., et al. Common variations in PSMD3-CSF3 and PLCB4 are associated with neutrophil count. Hum. Mol. Genet. 2010, 19:2079-2085.
64. Kamatani Y., et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 2010, 42:210-215.
65. Suarez-Alvarez B., et al. DNA methylation: a promising landscape for immune system-related diseases. Trends Genet. 2012, 28:506-514.
66. Costenbader K.H., et al. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmun. Rev. 2012, 11:604-609.
67. Karlson E.W., et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69:54-60.
68. Costenbader K.H., et al. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res. Ther. 2008, 10:R52.
69. Ramagopalan S.V., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res. 2010, 20:1352-1360.
70. Ramagopalan S.V., et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009, 5:e1000369.
71. Lessard C.J., et al. The genomics of autoimmune disease in the era of genome-wide association studies and beyond. Autoimmun. Rev. 2012, 11:267-275.
72. Mathew C.G. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat. Rev. Genet. 2008, 9:9-14.
73. Wang K., et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am. J. Hum. Genet. 2009, 84:399-405.
74. Bottini N., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 2004, 36:337-338.
75. McCarthy M.I., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 2008, 9:356-369.
76. Grice E.A., Segre J.A. The human microbiome: our second genome. Annu. Rev. Genomics Hum. Genet. 2012, 13:151-170.
77. Shui J.W., et al. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 2012, 488:222-225.
78. Gregory A.P., et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012, 488:508-511.
79. Hodges E., et al. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol. Cell 2011, 44:17-28.
80. Maier H., et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 2004, 5:1069-1077.
81. Cobb R.M., et al. Accessibility control of V(D)J recombination. Adv. Immunol. 2006, 91:45-109.
82. Quintin J., et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012, 12:223-232.
83. Eichler E.E., et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 2010, 11:446-450.
84. Ng S.B., et al. Massively parallel sequencing and rare disease. Hum. Mol. Genet. 2010, 19:R119-R124.
85. Netea M.G., et al. Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol. 2012, 13:535-542.